Skip to Content


In the US, Dofetilide (dofetilide systemic) is a member of the drug class group III antiarrhythmics and is used to treat Arrhythmia.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antiarrhythmic agent, class III

Chemical Names

3'-{2-[(4-Metylsulfonylaminophenetyl)metylamino]etoxy}metansulfonanilid (IUPAC)

beta-[(p-Metanesulfonamidophenetyl)metylamino]metanesulfono-p-phenetidide (WHO)

Metanesulfonamide, N-(4-(2-(metyl(2-(4-((metylsulfonyl)amino)phenoxy)etyl)amino)etyl)phenyl)-

Foreign Names

  • Dofetilidum (Latin)
  • Dofetilid (German)
  • Dofétilide (French)
  • Dofetilida (Spanish)

Generic Names

  • Dofetilide (OS: BAN, USAN, JAN)
  • Dofétilide (OS: DCF)
  • UK 68798 (IS: Pfizer)
  • Dofetilide (PH: USP 38)

Brand Name

  • Tikosyn
    Pfizer U.S., United States

← International Drug Name Search


BANBritish Approved Name
DCFDénomination Commune Française
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.